Log in to save to my catalogue

Delivery is key: lessons learnt from developing splice‐switching antisense therapies

Delivery is key: lessons learnt from developing splice‐switching antisense therapies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dc24c7db81c9430cadef6dc5077b7915

Delivery is key: lessons learnt from developing splice‐switching antisense therapies

About this item

Full title

Delivery is key: lessons learnt from developing splice‐switching antisense therapies

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2017-05, Vol.9 (5), p.545-557

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The use of splice‐switching antisense therapy is highly promising, with a wealth of pre‐clinical data and numerous clinical trials ongoing. Nevertheless, its potential to treat a variety of disorders has yet to be realized. The main obstacle impeding the clinical translation of this approach is the relatively poor delivery of antisense oligonucleot...

Alternative Titles

Full title

Delivery is key: lessons learnt from developing splice‐switching antisense therapies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dc24c7db81c9430cadef6dc5077b7915

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dc24c7db81c9430cadef6dc5077b7915

Other Identifiers

ISSN

1757-4676,1757-4684

E-ISSN

1757-4684

DOI

10.15252/emmm.201607199